Tag: insulinLikeGrowthFactor
Insulin like growth factor (IGF): Insulin-like growth factors (primarily IGF-I and IGF-II) are peptide hormones with growth promoting and other activities. IGFs are secreted from many types of cells. IGF-1 is required for mammary development at puberty and has been implicated in increased breast cancer risk.
Articles
- High glycemic load should be avoided in breast cancer diet
- Type 2 diabetes increases breast cancer risk
News
- 02/15/21
- Time-restricted eating inhibits mammary tumor growth in obese mice
- 04/28/13
- High circulating insulin increases HER2+ tumor size and metastases
- 03/04/13
- Fasting is more effective than calorie cut in model of chemotherapy
- 04/03/11
- Soy protein may heighten risk of BC by influencing cell signaling
Studies
-
Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy
Cite
Song D, Wu Y, Li J, Liu J, Yi Z, Wang X, et al. Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy. Journal of Clinical Investigation. American Society for Clinical Investigation; 2024; 134 10.1172/jci183366
-
Abstract 707: Calorie restriction to augment radiation response in models of Black women with breast cancer
Cite
Francois NB, Shastri AA, Harding S, DeAngelis T, Adekeye A, Simone N. Abstract 707: Calorie restriction to augment radiation response in models of Black women with breast cancer. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:707-707 10.1158/1538-7445.am2024-707
-
Abstract 2218: Dietary insulinemic potential and survival after breast cancer diagnosis
Cite
Romanos-Nanclares A, Wang T, Rosner BA, Holmes MD, Chen WY, Willett WC, et al. Abstract 2218: Dietary insulinemic potential and survival after breast cancer diagnosis. Cancer Research. American Association for Cancer Research (AACR); 2024; 84:2218-2218 10.1158/1538-7445.am2024-2218
-
Antidiabetic Drugs in Breast Cancer Patients
Cite
Garczorz W, Kosowska A, Francuz T. Antidiabetic Drugs in Breast Cancer Patients. Cancers. MDPI AG; 2024; 16:299 10.3390/cancers16020299
-
Dietary approaches for exploiting metabolic vulnerabilities in cancer
Cite
Menyhárt O, Győrffy B. Dietary approaches for exploiting metabolic vulnerabilities in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. Elsevier BV; 2023;:189062 10.1016/j.bbcan.2023.189062
-
Association between prediabetes and breast cancer: a comprehensive meta-analysis
Cite
Keesari PR, Jain A, Ganampet NR, Subhasri GSD, Edusa S, Muslehuddin Z, et al. Association between prediabetes and breast cancer: a comprehensive meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07181-x
-
Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells
Cite
Monteiro M, Zhang X, Yee D. Insulin promotes growth in breast cancer cells through the type I IGF receptor in insulin receptor deficient cells. Experimental Cell Research. Elsevier BV; 2023;:113862 10.1016/j.yexcr.2023.113862
-
Nutritional Metabolomics in Diet–Breast Cancer Relations: Current Research, Challenges, and Future Directions—A Review
Cite
Vahid F, Hajizadeghan K, Khodabakhshi A. Nutritional Metabolomics in Diet–Breast Cancer Relations: Current Research, Challenges, and Future Directions—A Review. Biomedicines. MDPI AG; 2023; 11:1845 10.3390/biomedicines11071845
-
The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression
Cite
Melnik BC, John SM, Carrera-Bastos P, Cordain L, Leitzmann C, Weiskirchen R, et al. The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression. Current Nutrition Reports. Springer Science and Business Media LLC; 2023; 10.1007/s13668-023-00457-0
-
Anticancer activity of apple peel extracts against human breast cancer cells through insulin-like growth factor-1 signal transduction pathway
Cite
Sair AT, Li Y, Zhao W, Li T, Liu RH. Anticancer activity of apple peel extracts against human breast cancer cells through insulin-like growth factor-1 signal transduction pathway. Journal of Agriculture and Food Research. Elsevier BV; 2023;:100507 10.1016/j.jafr.2023.100507
-
The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target
Cite
Lee J, Tocheny CE, Shaw LM. The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target. Life. MDPI AG; 2022; 12:1992 10.3390/life12121992
-
Effects of Exercise on Inflammatory Factors and IGF System in Breast Cancer Survivors: A Meta-analysis
Cite
Zhou Y, Jia N, Ding M. Effects of Exercise on Inflammatory Factors and IGF System in Breast Cancer Survivors: A Meta-analysis. Research Square Platform LLC; 2022; 10.21203/rs.3.rs-1137697/v1
-
Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
Cite
Vella V, Giuliano M, La Ferlita A, Pellegrino M, Gaudenzi G, Alaimo S, et al. Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells. Cells. MDPI AG; 2021; 10:3145 10.3390/cells10113145
-
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts
Cite
Cirillo F, Pellegrino M, Talia M, Perrotta ID, Rigiracciolo DC, Spinelli A, et al. Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts. Clinical and Translational Medicine. Wiley; 2021; 11 10.1002/ctm2.516
-
Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study
Cite
Tan VY, Bull CJ, Biernacka KM, Teumer A, Richardson TG, Sanderson E, et al. Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2021;:cebp.0315.2021 10.1158/1055-9965.epi-21-0315
-
Using dynamic cell communication improves treatment strategies of breast cancer
Cite
Liu Z, Hu S, Yun Z, Hu W, Zhang S, Luo D. Using dynamic cell communication improves treatment strategies of breast cancer. Cancer Cell International. Springer Science and Business Media LLC; 2021; 21 10.1186/s12935-021-01979-9
-
Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank
Cite
Tin Tin S, Reeves GK, Key TJ. Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank. British Journal of Cancer. Springer Science and Business Media LLC; 2021; 10.1038/s41416-021-01392-z
-
Quercetin blocks the aggressive phenotype of triple negative breast cancer by inhibiting IGF1/IGF1R-mediated EMT program
Cite
Chen W, Tsai J, Hsu L, Lin C, Hong H, Pan M. Quercetin blocks the aggressive phenotype of triple negative breast cancer by inhibiting IGF1/IGF1R-mediated EMT program. Journal of Food and Drug Analysis. The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA); 2021; 29:98-112 10.38212/2224-6614.3090
-
Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort
Cite
Monson KR, Goldberg M, Wu H, Santella RM, Chung WK, Terry MB. Circulating growth factor concentrations and breast cancer risk: a nested case-control study of IGF-1, IGFBP-3, and breast cancer in a family-based cohort. Breast Cancer Research. Springer Science and Business Media LLC; 2020; 22 10.1186/s13058-020-01352-0
-
Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer
Cite
Xue L, Chen F, Yue F, Camacho L, Kothapalli S, Wei G, et al. Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2020; 10.1007/s10549-020-05927-5
-
Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk
Cite
Biro FM, Huang B, Wasserman H, Gordon CM, Pinney SM. Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk. Journal of Adolescent Health. Elsevier BV; 2020; 10.1016/j.jadohealth.2020.07.016
-
Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women
Cite
Murphy N, Knuppel A, Papadimitriou N, Martin R, Tsilidis K, Smith-Byrne K, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ∼430 000 women. Annals of Oncology. Elsevier BV; 2020; 31:641-649 10.1016/j.annonc.2020.01.066
-
Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells
Cite
Sarfstein R, Nagaraj K, LeRoith D, Werner H. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells. Cells. MDPI AG; 2019; 8:1499 10.3390/cells8121499
-
Association of dietary intake of milk and dairy products with blood concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults
Cite
Romo Ventura E, Konigorski S, Rohrmann S, Schneider H, Stalla GK, Pischon T, et al. Association of dietary intake of milk and dairy products with blood concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults. European Journal of Nutrition. Springer Science and Business Media LLC; 2019; 59:1413-1420 10.1007/s00394-019-01994-7
-
The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark
Cite
Kalledsøe L, Dragsted LO, Hansen L, Kyrø C, Grønbæk H, Tjønneland A, et al. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark. Growth Hormone & IGF Research. Elsevier BV; 2019; 44:33-42 10.1016/j.ghir.2018.12.003
-
Obesity-Activated Adipose-Derived Stromal Cells Promote Breast Cancer Growth and Invasion
Cite
Hillers LE, D'Amato JV, Chamberlin T, Paderta G, Arendt LM. Obesity-Activated Adipose-Derived Stromal Cells Promote Breast Cancer Growth and Invasion. Neoplasia. Elsevier BV; 2018; 20:1161-1174 10.1016/j.neo.2018.09.004
-
Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer
Cite
Iida M, Tsuboi K, Niwa T, Ishida T, Hayashi S. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer. Breast Cancer. Springer Science and Business Media LLC; 2018; 26:272-281 10.1007/s12282-018-0922-0
-
A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
Cite
Pasanisi P, Bruno E, Venturelli E, Morelli D, Oliverio A, Baldassari I, et al. A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers. Cancers. MDPI AG; 2018; 10:309 10.3390/cancers10090309
-
Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): Results of CALGB (Alliance) 70806.
Cite
Wood M, Seisler DK, Hsieh M, Kontos D, Ambaye AB, Le-Petross HT, et al. Influence of vitamin D (Vit D) on mammographic density (MD) and insulin like growth factor 1 (IGF1): Results of CALGB (Alliance) 70806.. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018; 36:1549-1549 10.1200/jco.2018.36.15_suppl.1549
-
Obesity and breast cancer in premenopausal women: Current evidence and future perspectives
Cite
Laudisio D, Muscogiuri G, Barrea L, Savastano S, Colao A. Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. European Journal of Obstetrics & Gynecology and Reproductive Biology. Elsevier BV; 2018; 230:217-221 10.1016/j.ejogrb.2018.03.050
-
Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
Cite
Ireland L, Santos A, Campbell F, Figueiredo C, Hammond D, Ellies LG, et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene. Springer Science and Business Media LLC; 2018; 37:2022-2036 10.1038/s41388-017-0115-x
-
Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production
Cite
ter Braak B, Siezen CL, Lee JS, Rao P, Voorhoeve C, Ruppin E, et al. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production. Breast Cancer Research. Springer Science and Business Media LLC; 2017; 19 10.1186/s13058-017-0802-0
-
Analysis of the IGF-system in milk from farm animals – Occurrence, regulation, and biomarker potential
Cite
Meyer Z, Höflich C, Wirthgen E, Olm S, Hammon HM, Hoeflich A. Analysis of the IGF-system in milk from farm animals – Occurrence, regulation, and biomarker potential. Growth Hormone & IGF Research. Elsevier BV; 2017; 35:1-7 10.1016/j.ghir.2017.05.004
-
The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis
Cite
Meneses-Echávez JF, Jiménez EG, Río-Valle JS, Correa-Bautista JE, Izquierdo M, Ramírez-Vélez R. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer. Springer Science and Business Media LLC; 2016; 16 10.1186/s12885-016-2733-z
-
Metformin may protect nondiabetic breast cancer women from metastasis
Cite
EL-Haggar SM, El-Shitany NA, Mostafa MF, El-Bassiouny NA. Metformin may protect nondiabetic breast cancer women from metastasis. Clinical & Experimental Metastasis. Springer Science and Business Media LLC; 2016; 33:339-357 10.1007/s10585-016-9782-1
-
Implication of milk and dairy products consumption through insulin-like growth factor-I in induction of breast cancer risk factors in women
Cite
Maliou D, Bitam A. Implication of milk and dairy products consumption through insulin-like growth factor-I in induction of breast cancer risk factors in women. Nutrition Clinique et Métabolisme. Elsevier BV; 2015; 29:219-225 10.1016/j.nupar.2015.09.006
-
Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGFI Receptor
Cite
Emond JA, Pierce JP, Natarajan L, Gapuz LR, Nguyen J, Parker BA, et al. Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGFI Receptor. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2014; 23:1273-1279 10.1158/1055-9965.epi-13-1218
-
Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population
Cite
Levine M, Suarez J, Brandhorst S, Balasubramanian P, Cheng C, Madia F, et al. Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population. Cell Metabolism. Elsevier BV; 2014; 19:407-417 10.1016/j.cmet.2014.02.006
-
Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis
Cite
Saldana SM, Lee H, Lowery FJ, Khotskaya YB, Xia W, Zhang C, et al. Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis. PLoS ONE. Public Library of Science (PLoS); 2013; 8:e73406 10.1371/journal.pone.0073406
-
Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer
Cite
Hartog H, Boezen H, de Jong M, Schaapveld M, Wesseling J, van der Graaf W. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer. The Breast. Elsevier BV; 2013; 22:1155-1160 10.1016/j.breast.2013.07.038
-
Growth Hormone Potentiates 17β-Estradiol-Dependent Breast Cancer Cell Proliferation Independently of IGF-I Receptor Signaling
Cite
Felice DL, El-Shennawy L, Zhao S, Lantvit DL, Shen Q, Unterman TG, et al. Growth Hormone Potentiates 17β-Estradiol-Dependent Breast Cancer Cell Proliferation Independently of IGF-I Receptor Signaling. Endocrinology. The Endocrine Society; 2013; 154:3219-3227 10.1210/en.2012-2208
-
Animal Protein Intakes during Early Life and Adolescence Differ in Their Relation to the Growth Hormone-Insulin-Like-Growth-Factor Axis in Young Adulthood
Cite
Joslowski G, Remer T, Assmann KE, Krupp D, Cheng G, Garnett SP, et al. Animal Protein Intakes during Early Life and Adolescence Differ in Their Relation to the Growth Hormone-Insulin-Like-Growth-Factor Axis in Young Adulthood. The Journal of Nutrition. Oxford University Press (OUP); 2013; 143:1147-1154 10.3945/jn.113.175877
-
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer
Cite
Ferguson RD, Gallagher EJ, Cohen D, Tobin-Hess A, Alikhani N, Novosyadlyy R, et al. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer. Endocrine-Related Cancer. Bioscientifica; 2013; 20:391-401 10.1530/erc-12-0333
-
Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model
Cite
Rostoker R, Bitton-Worms K, Caspi A, Shen-Orr Z, LeRoith D. Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model. Endocrinology. The Endocrine Society; 2013; 154:1701-1710 10.1210/en.2012-2263
-
Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression
Cite
Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD. Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Experimental Gerontology. Elsevier BV; 2013; 48:1120-1128 10.1016/j.exger.2013.02.016
-
Abstract 585: Eicosapentaenoic acid increases mammary tumor inhibition of intermittent calorie restriction and regulates adipokines
Cite
Mizuno NK, Rogozina OP, Seppanen CM, Liao DJ, Cleary MP, Grossmann ME. Abstract 585: Eicosapentaenoic acid increases mammary tumor inhibition of intermittent calorie restriction and regulates adipokines. Prevention Research. American Association for Cancer Research; 2012; 10.1158/1538-7445.am2012-585
-
IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression
Cite
Ford NA, Nunez NP, Holcomb VB, Hursting SD. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression. Endocrine-Related Cancer. Bioscientifica; 2012; 20:39-51 10.1530/erc-12-0329
-
Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation
Cite
Sirianni R, Capparelli C, Chimento A, Panza S, Catalano S, Lanzino M, et al. Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation. Molecular and Cellular Endocrinology. Elsevier BV; 2012; 363:100-110 10.1016/j.mce.2012.08.002
-
Dose‐dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin‐like growth factor‐1
Cite
Nogueira LM, Lavigne JA, Chandramouli GVR, Lui H, Barrett JC, Hursting SD. Dose‐dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin‐like growth factor‐1. Cancer Medicine. Wiley; 2012; 1:275-288 10.1002/cam4.23
-
Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients
Cite
Fine EJ, Segal-Isaacson C, Feinman RD, Herszkopf S, Romano MC, Tomuta N, et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: A pilot safety and feasibility dietary trial in 10 patients. Nutrition. Elsevier BV; 2012; 28:1028-1035 10.1016/j.nut.2012.05.001
-
Indole-3-Carbinol disrupts Estrogen Receptor-alpha dependent expression of Insulin-like Growth Factor-1 Receptor and Insulin Receptor Substrate-1 and proliferation of human breast cancer cells
Cite
Marconett CN, Singhal AK, Sundar SN, Firestone GL. Indole-3-Carbinol disrupts Estrogen Receptor-alpha dependent expression of Insulin-like Growth Factor-1 Receptor and Insulin Receptor Substrate-1 and proliferation of human breast cancer cells. Molecular and Cellular Endocrinology. Elsevier BV; 2012; 363:74-84 10.1016/j.mce.2012.07.008
-
Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Cite
Romieu I, Ferrari P, Rinaldi S, Slimani N, Jenab M, Olsen A, et al. Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2012; 96:345-355 10.3945/ajcn.111.026724
-
High glycemic diet and breast cancer occurrence in the Italian EPIC cohort
Cite
Sieri S, Pala V, Brighenti F, Agnoli C, Grioni S, Berrino F, et al. High glycemic diet and breast cancer occurrence in the Italian EPIC cohort. Nutrition, Metabolism and Cardiovascular Diseases. Elsevier BV; 2013; 23:628-634 10.1016/j.numecd.2012.01.001
-
Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients
Cite
Lee C, Longo VD. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene. Springer Science and Business Media LLC; 2011; 30:3305-3316 10.1038/onc.2011.91
-
Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index
Cite
Lee C, Safdie FM, Raffaghello L, Wei M, Madia F, Parrella E, et al. Reduced Levels of IGF-I Mediate Differential Protection of Normal and Cancer Cells in Response to Fasting and Improve Chemotherapeutic Index. Cancer Research. American Association for Cancer Research (AACR); 2010; 70:1564-1572 10.1158/0008-5472.can-09-3228
-
Fasting and differential chemotherapy protection in patients
Cite
Raffaghello L, Safdie F, Bianchi G, Dorff T, Fontana L, Longo VD. Fasting and differential chemotherapy protection in patients. Cell Cycle. Informa UK Limited; 2010; 9:4474-4476 10.4161/cc.9.22.13954
-
Effects of Energy Restriction and Wheel Running on Mammary Carcinogenesis and Host Systemic Factors in a Rat Model
Cite
Zhu Z, Jiang W, Zacher JH, Neil ES, McGinley JN, Thompson HJ. Effects of Energy Restriction and Wheel Running on Mammary Carcinogenesis and Host Systemic Factors in a Rat Model. Cancer Prevention Research. American Association for Cancer Research (AACR); 2012; 5:414-422 10.1158/1940-6207.capr-11-0454
-
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
Cite
He X, Esteva F, Ensor J, Hortobagyi G, Lee M, Yeung SJ. Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Annals of Oncology. Elsevier BV; 2012; 23:1771-1780 10.1093/annonc/mdr534
-
Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer
Cite
Mabrok HB, Klopfleisch R, Ghanem KZ, Clavel T, Blaut M, Loh G. Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis. Oxford University Press (OUP); 2011; 33:203-208 10.1093/carcin/bgr256
-
Cell signaling pathways associated with a reduction in mammary cancer burden by dietary common bean ( Phaseolus vulgaris L.)
Cite
Thompson MD, Mensack MM, Jiang W, Zhu Z, Lewis MR, McGinley JN, et al. Cell signaling pathways associated with a reduction in mammary cancer burden by dietary common bean ( Phaseolus vulgaris L.). Carcinogenesis. Oxford University Press (OUP); 2011; 33:226-232 10.1093/carcin/bgr247
-
Alcohol Exposure In Utero Leads to Enhanced Prepubertal Mammary Development and Alterations in Mammary IGF and Estradiol Systems
Cite
Polanco TA, Crismale-Gann C, Cohick WS. Alcohol Exposure In Utero Leads to Enhanced Prepubertal Mammary Development and Alterations in Mammary IGF and Estradiol Systems. Hormones and Cancer. Springer Science and Business Media LLC; 2011; 2:239-248 10.1007/s12672-011-0074-6
-
Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors
Cite
Dogan S, Johannsen A, Grande J, Cleary M. Effects of Intermittent and Chronic Calorie Restriction on Mammalian Target of Rapamycin (mTOR) and IGF-I Signaling Pathways in Mammary Fat Pad Tissues and Mammary Tumors. Nutrition and Cancer. Informa UK Limited; 2011; 63:389-401 10.1080/01635581.2011.535968
-
Effects of Tomato- and Soy-Rich Diets on the IGF-I Hormonal Network: A Crossover Study of Postmenopausal Women at High Risk for Breast Cancer
Cite
McLaughlin JM, Olivo-Marston S, Vitolins MZ, Bittoni M, Reeves KW, Degraffinreid CR, et al. Effects of Tomato- and Soy-Rich Diets on the IGF-I Hormonal Network: A Crossover Study of Postmenopausal Women at High Risk for Breast Cancer. Cancer Prevention Research. American Association for Cancer Research (AACR); 2011; 4:702-710 10.1158/1940-6207.capr-10-0329
-
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
Cite
Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2009; 123:333-344 10.1007/s10549-009-0647-z
-
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth
Cite
Casa AJ, Potter AS, Malik S, Lazard Z, Kuiatse I, Kim H, et al. Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2011; 132:61-73 10.1007/s10549-011-1540-0
-
Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats
Cite
Nielsen TS, Khan G, Davis J, Michels KB, Hilakivi-Clarke L. Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats. International Journal of Cancer. Wiley; 2010; 128:12-20 10.1002/ijc.25313
-
Abstract 5085: Formerly obese mice display increased mmtv-wnt-1 tumor growth despite normalization of body weight: The role of mTOR
Cite
De Angel RE, Tekmal RR, Perkins SN, deGraffenried LA, Hursting SD. Abstract 5085: Formerly obese mice display increased mmtv-wnt-1 tumor growth despite normalization of body weight: The role of mTOR. Cellular and Molecular Biology. American Association for Cancer Research; 2010; 10.1158/1538-7445.am10-5085
-
Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity
Cite
Kalla Singh S, Tan Q, Brito C, De León M, Garberoglio C, De León D. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity. Growth Hormone & IGF Research. Elsevier BV; 2010; 20:162-170 10.1016/j.ghir.2009.12.002
-
A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats
Cite
Moulton CJ, Valentine RJ, Layman DK, Devkota S, Singletary KW, Wallig MA, et al. A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats. Nutrition & Metabolism. Springer Science and Business Media LLC; 2010; 7:1 10.1186/1743-7075-7-1
-
Examining Breast Cancer Growth and Lifestyle Risk Factors: Early Life, Childhood, and Adolescence
Cite
Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ. Examining Breast Cancer Growth and Lifestyle Risk Factors: Early Life, Childhood, and Adolescence. Clinical Breast Cancer. Elsevier BV; 2008; 8:334-342 10.3816/cbc.2008.n.038
-
Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk
Cite
Lagiou P, Hsieh CC, Lipworth L, Samoli E, Okulicz W, Troisi R, et al. Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk. British Journal of Cancer. Springer Science and Business Media LLC; 2009; 100:1794-1798 10.1038/sj.bjc.6605074
-
The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells
Cite
Xia Y, Jin L, Zhang B, Xue H, Li Q, Xu Y. The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells. Life Sciences. Elsevier BV; 2007; 80:2161-2169 10.1016/j.lfs.2007.04.008
-
Mechanisms Associated with Dose-Dependent Inhibition of Rat Mammary Carcinogenesis by Dry Bean (Phaseolus vulgaris, L.)
Cite
Thompson MD, Thompson HJ, Brick MA, McGinley JN, Jiang W, Zhu Z, et al. Mechanisms Associated with Dose-Dependent Inhibition of Rat Mammary Carcinogenesis by Dry Bean (Phaseolus vulgaris, L.). The Journal of Nutrition. Oxford University Press (OUP); 2008; 138:2091-2097 10.3945/jn.108.094557
-
Resveratrol inhibits migration and invasion of human breast-cancer cells
Cite
Tang F, Su Y, Chen N, Hsieh H, Chen K. Resveratrol inhibits migration and invasion of human breast-cancer cells. Molecular Nutrition & Food Research. Wiley; 2008; 52:683-691 10.1002/mnfr.200700325
-
Milk Inhibits the Regression of 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Ovariectomized Rats
Cite
Qin L, Xu J, Tezuka H, Wang P, Hoshi K. Milk Inhibits the Regression of 7,12-Dimethylbenz(a)anthracene-Induced Mammary Tumors in Ovariectomized Rats. Nutrition and Cancer. Informa UK Limited; 2008; 60:505-510 10.1080/01635580801927452
-
Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway
Cite
Vatten LJ, Holly JM, Gunnell D, Tretli S. Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:2097-2100 10.1158/1055-9965.epi-08-0212
-
Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions
Cite
Kleinberg DL, Wood TL, Furth PA, Lee AV. Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions. Endocrine Reviews. The Endocrine Society; 2008; 30:51-74 10.1210/er.2008-0022
-
Association between Alcohol Intake and Serum Sex Hormones and Peptides Differs by Tamoxifen Use in Breast Cancer Survivors
Cite
Wayne S, Neuhouser ML, Ulrich CM, Koprowski C, Wiggins C, Baumgartner KB, et al. Association between Alcohol Intake and Serum Sex Hormones and Peptides Differs by Tamoxifen Use in Breast Cancer Survivors. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2008; 17:3224-3232 10.1158/1055-9965.epi-08-0171